...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL, DICLOFENAC POTASSIUM AND CHLORZOXAZONE IN BULK DRUG AND TABLET DOSAGE FORM
【24h】

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL, DICLOFENAC POTASSIUM AND CHLORZOXAZONE IN BULK DRUG AND TABLET DOSAGE FORM

机译:高效液相色谱法同时估算散装毒品和片剂剂量形式中的帕拉西莫尔,双氯芬酸钾和氯唑酮的开发和验证

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: Research study was undertaken to develop and validate simple, rapid, precise, accurate, robust High Performance Thin Layer Chromatographic (HPTLC) method for simultaneous determination of paracetamol (PARA), diclofenac potassium (DCL) and chlorzoxazone (CHL) in bulk drug and tablet dosage form. Methods: The chromatographic separation was performed on precoated silica gel G 60 F254plates with toluene: ethyl acetate [55:45, v/v] as mobile phase. The detection was carried out at 271 nm. Results: Retention factors of PARA, DCL and CHL were found to be 0.21 ± 0.01, 0.54 ± 0.01, and 0.74 ± 0.01, respectively. Linearity of PARA, DCL and CHL was found to be in the concentration range of 1000-3500 ng band-1, 100-350 ng band-1 and 500-1750 ng band-1, respectively. The % assay (Mean ± S.D.) was found to be 100.63 % ± 1.2, 103.46 ± 1.58 and 101.85 % ± 1.92 for PARA, DCL and CHL, respectively. Method was validated for linearity, accuracy, precision, specificity, robustness in accordance with International Conference on Harmonisation [ICH] guidelines. Conclusion: The proposed HPTLC method has been successfully applied for the analysis of drugs in tablet dosage formulation and applicable to routine analysis PARA, DCL and CHL in bulk drug and tablet dosage form
机译:目的:进行研究研究以开发和验证简单,快速,准确,准确,可靠的高效薄层色谱(HPTLC)方法,用于同时测定散装药物中的扑热息痛(PARA),双氯芬酸钾(DCL)和氯唑沙宗(CHL)和片剂剂型。方法:色谱分离是在预涂硅胶G 60 F254板上,以甲苯:乙酸乙酯[55:45,v / v]为流动相。该检测在271nm进行。结果:发现PARA,DCL和CHL的保留因子分别为0.21±0.01、0.54±0.01和0.74±0.01。发现PARA,DCL和CHL的线性分别在1000-3500ng band-1、100-350ng band-1和500-1750ng band-1的浓度范围内。发现PARA,DCL和CHL的%测定(平均值±标准差)分别为100.63%±1.2、103.46±1.58和101.85%±1.92。根据国际协调会议[ICH]指南,对方法的线性,准确性,精密度,特异性,鲁棒性进行了验证。结论:所提出的HPTLC方法已成功应用于片剂剂型中药物的分析,并可用于常规分析散剂和片剂剂型中的PARA,DCL和CHL

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号